Alzheimer's Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection.
Level 5 - mechanism / opinion, no new human data
Preclinical bench and animal research (in vitro and transgenic mouse models) without clinical human data.
PubMed 30001512 · doi:10.1016/j.neuron.2018.06.030
What was done
Researchers investigated whether amyloid-β (Aβ) oligomers interact with neurotropic herpesviruses. They evaluated β-amyloid deposition and viral entrapment using 5XFAD transgenic mouse models and 3D human neural cell culture models challenged with herpes simplex virus 1 (HSV-1) and human herpesviruses 6A and 6B (HHV-6A and HHV-6B).
What was found
The abstract provides no quantitative metrics. It reports that Aβ oligomers bound to herpesvirus surface glycoproteins, accelerating β-amyloid deposition and resulting in protective viral entrapment against HSV-1, HHV-6A, and HHV-6B in both the 5XFAD mouse and 3D cell culture models.
Why it matters
These findings suggest that β-amyloid may function as an antimicrobial peptide within CNS innate immunity, providing a potential mechanism by which herpesvirus infections could directly trigger or accelerate Alzheimer's disease pathology.
Limits
The study is restricted to in vitro 3D cell cultures and transgenic animal models, which may not reflect human disease progression. The abstract does not report sample sizes, effect sizes, statistical comparisons, or clinical human validation.
Cited by
- supports Rudy Tanzi's research demonstrated that microbes, viruses, and bacteria from the microbiome are present in brain biopsies of Alzheimer's patients, triggering amyloid plaque deposition as an immune response.